Our lab is focused on understanding the molecular mechanisms that drive therapeutic resistance to targeted therapies in breast and other cancers. We are particularly interested in characterizing how these mechanisms differ by organ/site of metastasis and we aim to use this insight to develop more effective therapeutic strategies for metastatic cancer.
Research lines:
Research lines:
- Mechanisms of resistance to targeted therapies
- Therapeutic strategies for metastatic cancers
- Cell signaling pathways in cancer